Vimarsana
Biggest News Aggregation in the World

Ella Mendelson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ella Mendelson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ella Mendelson Today - Breaking & Trending Today

UMich students gather for pro-Israel rally on the Diag - Vimarsana News

UMich students gather for pro-Israel rally on the Diag

Students and community members gathered on the Diag Wednesday afternoon for a rally marking six months since Hamas’ Oct. 7 attack on Israel.

Israeli scientists are working to determine COVID vaccine efficiency against omicron. This is how - Vimarsana News

Israeli scientists are working to determine COVID vaccine efficiency against omicron. This is how

The COVID omicron genome includes about 50 mutations that did not exist in the original version of the virus, and 32 of them are in the spike protein that binds the virus to cells in the body

Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection - Vimarsana News

Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection

/PRNewswire/ -- Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address...

Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection - Vimarsana News

Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection

/PRNewswire/ -- Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address...

Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection - Vimarsana News

Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection

NP-003 study terminated early with high significance in reducing viral infection. TEL AVIV , Israel, Nov. 24, 2021 /PRNewswire/ -- Nasus Pharma a privately held clinical-stage biopharmaceutical